Monday July 16, 2018
Home Uncategorized Shiv Sainiks ...

Shiv Sainiks protest at BCCI office in Mumbai

0
//
29
Republish
Reprint

Mumbai: A group of Shiv Sena activists on Monday protested at Indian cricket board president Shashank Manohar’s office here against his move to hold talks with Pakistan Cricket Board chief Shahryar Khan to resume cricket ties between the two countries.

The Shiv Sainiks, numbering over 70, carried a black flag and shouted slogans of “Pakistan murdabad”, “Shashank Manohar murdabad” and “Shahryar Khan Go Back”.

Later, police detained more than two dozen activists and whisked them away, even as the Board of Control for Cricket in India (BCCI) president quietly watched from his office.

A protester said the Shiv Sena would not allow any cricketing relations between the two countries until Pakistan stopped the killing of Indian soldiers and civilians at the border.

Shiv Sena MP Sanjay Raut, who is the executive editor of the Sena mouthpiece Saamana, said that it was not a gherao but a meeting with Manohar to urge him to cancel the negotiations with his Pakistani counterpart.

This is the second major protest within a fortnight by the Shiv Sena against Pakistan.

It started around 10 days ago when Pakistani ghazal maestro Ghulam Ali’s scheduled concerts in Mumbai and Pune were forced to be cancelled following Sena’s strong opposition.

Last Monday, Sena activists blackened the face of veteran journalist Sudheendra Kulkarni in an attempt to force him to cancel a book launch function of former Pakistani foreign minister Khurshid Mahmud Kasuri.

The move attracted condemnation, but following intervention by Chief Minister Devendra Fadnavis, the book release function passed off peacefully.

 

(IANS)

Click here for reuse options!
Copyright 2015 NewsGram

Next Story

Cepheid to Establish Manufacturing Unit for TB Diagnostics in India

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment

0
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach. (IANS)

Expanding its footprint in India, US-based molecular diagnostics company Cepheid Inc on Thursday announced its plans to establish a manufacturing unit in the country to improve Tuberculosis (TB) diagnostics.

Cepheid’s GeneXpert MTB/RIF test is a closed-cartridge-based system that is easy to operate by minimally trained staff and gives results in approximately two hours, speeding the conventional backlog that used to exist in traditional diagnostic methods.

The new manufacturing unit would produce MTB/RIF test cartridges, contribute to the government’s “Make in India” initiative and thus bringing the company’s global expertise in TB diagnostics to India, the company said in a statement.

As part of the plan, Cepheid also unveiled its latest portable, easy-to-use TB-testing system — the GeneXpert Edge — which is expected to be available in India later this year, the company said.

The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.

“Cepheid recognises the need for technological advancement and is committed to contributing significantly to India’s goal of TB eradication,” said Peter Farrell, Executive Vice President, Worldwide Commercial Operations, Cepheid.

Cepheid's Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB)
Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB).

“We are hopeful that GeneXpert Edge will help eliminate delays in TB diagnostics by providing definitive results within hours and facilitating fast and easy last-mile delivery even in the remote villages of India,” he added.

India has nearly one-fourth of the global TB patients and an estimated 4.8 lakh lives are lost every year due to delayed diagnosis and inadequate treatment and there are above 2.5 million new cases of TB every year. The country aims to eradicate TB by 2025.

Approved by the World Health Organisation (WHO) in 2010, more than 1,200 Cepheid’s GeneXpert Systems have been installed in the last two years at various Revised National Tuberculosis Control Programme (RNTCP) sites in the country and more than 2.5 million cartridges were supplied last year at various centres of Central TB Division (CTD).

Also Read: Fruit Bats Identified As Source Of Nipah Virus Outbreak in Kerala

Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB) and rifampicin-resistance mutations, which are markers for MDR-TB strains in under two hours.

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment.

Xpert MTB/RIF tests also have excellent negative predictive value, which allows clinicians to manage TB-negative patients more effectively to prevent unnecessary and costly respiratory isolations. (IANS)